RhumbLine Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Buy
128,732
+7,922
+7% +$74.2K ﹤0.01% 2155
2025
Q1
$1.48M Buy
120,810
+7,361
+6% +$90.4K ﹤0.01% 1964
2024
Q4
$1.5M Sell
113,449
-1,010
-0.9% -$13.4K ﹤0.01% 2032
2024
Q3
$2.2M Sell
114,459
-4,826
-4% -$92.9K ﹤0.01% 1853
2024
Q2
$2.45M Buy
119,285
+10,291
+9% +$211K ﹤0.01% 1781
2024
Q1
$2.59M Buy
108,994
+13,677
+14% +$326K ﹤0.01% 1777
2023
Q4
$2.06M Sell
95,317
-3,652
-4% -$78.9K ﹤0.01% 1889
2023
Q3
$1.44M Buy
98,969
+671
+0.7% +$9.74K ﹤0.01% 2019
2023
Q2
$2.06M Buy
98,298
+7,444
+8% +$156K ﹤0.01% 1892
2023
Q1
$1.92M Buy
90,854
+10,286
+13% +$217K ﹤0.01% 1826
2022
Q4
$2.05M Buy
80,568
+1,780
+2% +$45.3K ﹤0.01% 1772
2022
Q3
$1.89M Buy
78,788
+7,522
+11% +$181K ﹤0.01% 1798
2022
Q2
$1.37M Buy
71,266
+13,027
+22% +$251K ﹤0.01% 1968
2022
Q1
$1.01M Buy
58,239
+1,516
+3% +$26.3K ﹤0.01% 2126
2021
Q4
$1.24M Sell
56,723
-776
-1% -$17K ﹤0.01% 2120
2021
Q3
$1.1M Buy
57,499
+2,100
+4% +$40.1K ﹤0.01% 2182
2021
Q2
$951K Buy
55,399
+23,631
+74% +$406K ﹤0.01% 2265
2021
Q1
$710K Sell
31,768
-925
-3% -$20.7K ﹤0.01% 2339
2020
Q4
$727K Buy
32,693
+1,967
+6% +$43.7K ﹤0.01% 2278
2020
Q3
$454K Sell
30,726
-3,018
-9% -$44.6K ﹤0.01% 2328
2020
Q2
$500K Buy
33,744
+10,270
+44% +$152K ﹤0.01% 2345
2020
Q1
$258K Buy
23,474
+420
+2% +$4.62K ﹤0.01% 2468
2019
Q4
$202K Buy
23,054
+203
+0.9% +$1.78K ﹤0.01% 2745
2019
Q3
$171K Sell
22,851
-140
-0.6% -$1.05K ﹤0.01% 2784
2019
Q2
$214K Buy
22,991
+3,726
+19% +$34.7K ﹤0.01% 2769
2019
Q1
$101K Sell
19,265
-145
-0.7% -$760 ﹤0.01% 2856
2018
Q4
$86K Buy
19,410
+5,350
+38% +$23.7K ﹤0.01% 2900
2018
Q3
$114K Sell
14,060
-625
-4% -$5.07K ﹤0.01% 2849
2018
Q2
$103K Buy
+14,685
New +$103K ﹤0.01% 2869